Cure My Disease

Don't miss your cure!

 Log in / Sign up

New fabric brace could give arm strength back to patients with muscle diseases

NCT ID NCT06363357

Symptom relief Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 04, 2026 · Updated 2 times

Summary

This study tests a special fabric shoulder brace designed to mimic muscle support for people with neuromuscular disorders like muscular dystrophy, SMA, and ALS. About 30 participants will wear the brace and perform arm tasks to see if it improves movement, strength, and daily function. Researchers will compare results with and without the brace to measure its effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

8 people

The number who actually took part.

Started

Apr 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria 1. Patients with a confirmed diagnosis of a neuromuscular disease (NMD) by genetic testing, muscle biopsy, or electrodiagnostic studies, presenting with prominent upper limb muscle weakness. Examples include: 1. Muscular Dystrophies: Duchenne/Becker Muscular Dystrophy (DMD/BMD), Limb-Girdle Muscular Dystrophy (LGMD), Facioscapulohumeral Muscular Dystrophy (FSHD), etc. 2. Motor Neuron Diseases: Spinal Muscular Atrophy (SMA, Types 2 and 3), Amyotrophic Lateral Sclerosis (ALS, upper limb-dominant), etc. 3. Peripheral Neuropathies: Charcot-Marie-Tooth (CMT) disease, etc. 4. Other Neuromuscular Conditions: Including but not limited to cervical spinal cord injury. 2. Aged over 10 years. 3. A score of 2 to 5 on the Brooke Upper Extremity Functional Rating Scale. 4. Manual Muscle Test (MMT) grade of less than 3 for shoulder abduction. 5. Ability to provide written informed consent from the participant and/or their legal representative, indicating willingness to participate in the study. Exclusion Criteria 1. Unwillingness or inability to provide informed consent. 2. A score of 1 or 6 on the Brooke Upper Extremity Functional Rating Scale. 3. Cognitive impairment severe enough to interfere with the proper use of a shoulder orthosis. 4. Any other condition which, in the opinion of the investigator, would make study participation inappropriate or unsafe for the patient.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALS (amyotrophic lateral sclerosis) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis Becker muscular dystrophy Charcot-Marie-Tooth disease Duchenne muscular dystrophy facioscapulohumeral muscular dystrophy limb-girdle muscular dystrophy neuromuscular disease spinal cord injury spinal muscular atrophy spinal muscular atrophy, type II spinal muscular atrophy, type III

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALS (amyotrophic lateral sclerosis) Fascioscapulohumeral muscular dystrophy LGMD Muscular dystrophy, Duchenne Neuromuscular diseases (NMD) Orthotic devices Sci - spinal cord injury Spinal muscular atrophy (SMA) Upper extremity

Contacts and locations

Locations

  • Seoul National University Hospital

    Seoul, Jongno-gu, 03080, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.